Progyny, Inc. Income Taxes Paid
Progyny, Inc. (PGNY) reported Income Taxes Paid of $18.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-07
- Progyny, Inc. income taxes paid, net for the quarter ending 2026-06-30 was $18.34M, a 23.39% decline year-over-year.
- Progyny, Inc. income taxes paid, net for the quarter ending 2026-03-31 was $640.00K, a 60.00% increase year-over-year.
- Progyny, Inc. income taxes paid, net for the quarter ending 2025-12-31 was $15.59M, a 179.58% increase year-over-year.
- Progyny, Inc. income taxes paid, net for the quarter ending 2025-09-30 was $15.56M, a 11.39% decline year-over-year.
- Progyny, Inc. income taxes paid, net for fiscal 2025 was $55.49M, a 37.19% increase from fiscal 2024.
- Progyny, Inc. income taxes paid, net for fiscal 2024 was $40.45M, a 554.41% increase from fiscal 2023.
- Progyny, Inc. income taxes paid, net for fiscal 2023 was $6.18M, a 4547.37% increase from fiscal 2022.
- Progyny, Inc. income taxes paid, net for fiscal 2022 was $133.00K, a 37.11% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $18.98M 10-Q · filed 2026-08-07 | $34.57M derived: sum of 3 quarters · filed 2026-08-07 | $50.13M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $640.00K 10-Q · filed 2026-05-08 | $16.23M derived: sum of 2 quarters · filed 2026-05-08 | $31.79M derived: sum of 3 quarters · filed 2026-05-08 | $55.73M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $15.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $31.15M derived: sum of 2 quarters · filed 2026-02-27 | $55.09M derived: sum of 3 quarters · filed 2026-08-07 | $55.49M 10-K · filed 2026-02-27 |
| 2025-09-30 | $15.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $39.50M derived: sum of 2 quarters · filed 2026-08-07 | $39.90M 10-Q · filed 2025-11-07 | $45.48M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $23.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $24.34M 10-Q · filed 2026-08-07 | $29.92M derived: sum of 3 quarters · filed 2026-08-07 | $47.47M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $400.00K 10-Q · filed 2026-05-08 | $5.98M derived: sum of 2 quarters · filed 2026-05-08 | $23.53M derived: sum of 3 quarters · filed 2026-05-08 | $41.21M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $23.13M derived: sum of 2 quarters · filed 2026-02-27 | $40.81M derived: sum of 3 quarters · filed 2026-02-27 | $40.45M 10-K · filed 2026-02-27 |
| 2024-09-30 | $17.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $35.23M derived: sum of 2 quarters · filed 2025-11-07 | $34.87M 10-Q · filed 2025-11-07 | $38.73M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $17.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $17.32M 10-Q · filed 2025-08-08 | $21.18M derived: sum of 3 quarters · filed 2026-02-27 | $22.80M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$362.00K 10-Q · filed 2025-05-09 | $3.50M derived: sum of 2 quarters · filed 2026-02-27 | $5.12M derived: sum of 3 quarters · filed 2026-02-27 | $5.84M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.48M derived: sum of 2 quarters · filed 2026-02-27 | $6.20M derived: sum of 3 quarters · filed 2026-02-27 | $6.18M 10-K · filed 2026-02-27 |
| 2023-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.34M derived: sum of 2 quarters · filed 2024-11-12 | $2.32M 10-Q · filed 2024-11-12 | $2.31M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $718.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $698.00K 10-Q · filed 2024-08-07 | $685.00K derived: sum of 3 quarters · filed 2025-03-03 | $771.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$20.00K 10-Q · filed 2024-05-10 | -$33.00K derived: sum of 2 quarters · filed 2025-03-03 | $53.00K derived: sum of 3 quarters · filed 2025-03-03 | $108.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $73.00K derived: sum of 2 quarters · filed 2025-03-03 | $128.00K derived: sum of 3 quarters · filed 2025-03-03 | $133.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $141.00K derived: sum of 2 quarters · filed 2023-11-08 | $146.00K 10-Q · filed 2023-11-08 | $243.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $60.00K 10-Q · filed 2023-08-04 | $157.00K derived: sum of 3 quarters · filed 2024-02-29 | $157.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $5.00K 10-Q · filed 2023-05-09 | $102.00K derived: sum of 2 quarters · filed 2024-02-29 | $102.00K derived: sum of 3 quarters · filed 2024-02-29 | |
| 2021-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $97.00K derived: sum of 2 quarters · filed 2024-02-29 | $97.00K 10-K · filed 2024-02-29 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-05 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |